Big Pharma still betting on 'messed up' Indian drugs market

Global drugmakers have had a nauseous time in India's $14 billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the......

GSK to licence Roche cardiac drug for India

GlaxoSmithKline Pharmaceuticals Ltd is planning to in-licence the blockbuster cardiovascular drug, Carvedilol, of Swiss pharmaceuticals major Roche for the Indian market.Carvedilol is the first......

Nirmal to buy Glaxo property

Nirmal Constructions, a leading real estate and construction group, is set to acquire the 20 acre Burrows Wellcome property at Mulund (a Mumbai suburb) for nearly Rs 230 crore (Rs 2.3 billion).At......

Glaxo sells Worli plot for Rs 108 crore

Pharma major GlaxoSmithKline Pharmaceuticals Ltd has sold its Worli plot for Rs 107.6 crore (Rs 1.08 billion) to I-Ven Realty Ltd, a joint venture between ICICI Venture Funds Management Company Ltd......